USRE37270EExpiredUtility
Liquid crystal phase
Est. expirySep 8, 2006(expired)· nominal 20-yr term from priority
C09K 19/46C09K 19/2007C09K 19/3001C09K 19/3444C09K 19/3402C09K 19/3469C09K 2019/3422C09K 19/20C09K 19/34
29
PatentIndex Score
0
Cited by
20
References
19
Claims
Abstract
Liquid crystal phases containing components of the formulae I and IIIhave an acceptable combination of threshold steepness, viewing angle and temperature dependence at a low threshold voltage.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A liquid crystal phase consisting essentially of 4 to 36 wt.% of at least one component of the formula I
wherein R 1 is alkyl of 1 to 12 C atoms; at least one component of the formula II
R 1 —A 2 —Phe—CN II
wherein
A 2 is Cy, Phe, Phe—COO, Cy—COO, Phe—Phe, Phe—COO—Phe, Phe—PHe Phe—COO—Phe, Cy—Phe or Cy—COO—Phe,
Cy is trans-1,4-cyclohexylene,
Phe is 1,4-phenylene, and
R 1 has the meaning indicated above,
whereby the total proportion of compounds of the formulae I and II is more than 5 wt.%, 22to 71 wt.% of one or more components of the formula III
R 1 —A 3 —COO—Phe—R 2 III
wherein A 3 is Cy or Phe,
R 1 and R 2 each are independently alkyl of 1 to 12 C atoms, and Cy and Phe have the meanings indicated above;
0 to 25 wt.% of one or more components of the formula IV and/or VI
R 1 —A 3 —(Z 1 —A 3 ) 2 —R 2 IV
wherein Z 1 independently is —CO—O— or —O—CO—, m is 0 or 1 and R 1 , R 2 and A 3 independently have the meanings indicated above;
and 0 to 28 wt.% of compounds of the formula Va
R 1 —Dio—Phe—CN Va
wherein R 1 is alkyl of 1 to 7 C atoms, Dio is trans-1,3-dioxane-2,5-diyl and Phe is 1,4-phenylene.
2. A liquid crystal phase according to claim 1 , wherein said phase contains simultaneously compounds of formula III wherein A 3 is Cy and Phe.
3. A liquid crystal phase according to claim 1 , wherein said phase contains compounds of the formula IV selected from the following formulae IVa to IVf
R 1 —Phe—COO—Phe—COO—Phe—R 2 IVa
R 1 —Cy—COO—Phe—COO—Phe—R 2 IVb
R 1 —Phe—COO—Cy—COO—Phe—R 2 IVc
R 1 —Phe—OOC—Cy—COO—Phe—R 2 IVd
R 1 —Cy—COO—Cy—COO—Phe—R 2 IVe
R 1 —Cy—COO—Phe—COO—Cy—R 2 IVf.
4. A liquid crystal phase according to claim 1 , wherein said phase consists essentially of
10% of 4-cyano-4-fluorophenyl p-ethylbenzoate
9% of 4-cyano-3-fluorophenyl p-propylbenzoate
7% of 2-p-cyanophenyl-5-propyl-1,3-dioxane
20% of 4-cyanobiphenyl-4′-yl trans-4-ethylcyclohexanecarboxylate
10% of 4-propyl-4′-cyanobiphenyl
3% of 4-cyanobiphenyl-4′-yl p-(p-heptylphenyl)-benzoate
14.8% of p-pentylphenyl p-methylbenzoate
17.5% of p-pentylphenyl p-propylbenzoate
8.7% of p-pentylphenyl p-pentylbenzoate.
5. A liquid crystal phase according to claim 1 , wherein said phase consists essentially of
7% of 4-cyano-3-fluorophenyl p-ethylbenzoate
7% of 4-cyanobiphenyl-4′-yl trans-4-ethylcyclohexanecarboxylate
15% of 4-cyano-4′-(trans-4-pentylcyclohexyl)-biphenyl
4% of p-(p-propylhexoxycarbonyl)-phenyl trans-4-ethylcyclohexanecarboxylate
24.3% of pe-pentylphenyl p- pentylphenyl p-methylbenzoate
28.4% of p-pentylphenyl p-pentylbenzoate
14.3% of p-pentylphenyl p-pentylbenzoate.
6. A liquid crystal phase according to claim 1 , wherein said phase consists essentially of
10% of 4-cyano-3-fluorophenyl p-ethylbenzoate
10% of 4-cyano-3-fluorophenyl p-propylbenzoate
15% of 4-ethyl-4′-cyanobiphenyl
5% of 2-p-cyanophenyl-5-propyl-1,3-dioxane
20% of 4-cyanobiphenyl-4′-yl trans-4-ethylcyclohexanecarboxylate
2% of p-(p-propylphenoxycarbonyl)-phenyl trans-4-ethylcyclohexanecarboxylate
12% of p-propylphenyl trans-4-propylcyclohexanecarboxylate
14.6% of p-pentylphenyl trans-4-propylcyclohexanecarboxylate and
11.4% of p-heptylphenyl trans-4-propylcyclohexanecarboxylate.
7. A liquid crystal phase according to claim 1 , wherein said phase consists essentially of
10% of 4-cyano-3-fluorophenyl p-ethylbenzoate
8% of 4-cyanobiphenyl-4′-yl trans-4-ethylcyclohexanecarboxylate
8% of 4-cyano-4′-(trans-4-pentylcyclohexyl)-biphenyl
3% of 4-cyanobiphenyl-4′-yl p-(p-heptylphenyl)-benzoate
15.8% of p-pentylphenyl p-methylbenzoate
6.8% of p-pentylphenyl p-propylbenzoate
3.4% of p-pentylphenyl p-pentylbenzoate
14.2% of p-propylphenyl trans-4-propylcyclohexanecarboxylate
17.3% of p-pentylphenyl trans-4-propylcyclohexanecarboxylate and
13.5% of p-heptylphenyl trans-4-propylcyclohexanecarboxylate.
8. A liquid crystal phase according to claim 1 , wherein said phase consists consisting essentially of
5% of 4-cyano-3-fluorophenyl p-ethylbenzoate
5% of 4-cyano-3-fluorophenyl p-propylbenzoate
10% of 4-ethyl-4′-cyanobiphenyl
15% of 4-butyl-4′-cyanobiphenyl
15% of p-ethoxyphenyl trans-4-propylcyclohexanecarboxylate
15% of p-methoxyphenyl trans-4-butylcyclohexanecarboxylate
10% of p-methoxyphenyl trans-4-pentylcyclohexanecarboxylate
10% of p-ethoxyphenyl trans-4-butylcyclohexanecarboxylate
6% of p-propylphenyl trans-4-(p-propylphenoxycarbonyl)cyclohexanecarboxylate
5% of p-butylphenyl trans-4-(p-butylphenoxycarbonyl)cyclohexanecarboxylate and
4% of p-pentylphenyl trans-4-(p-pentylphenoxycarbonyl)cyclohexanecarboxylate.
9. A liquid crystal phase according to claim 1 , wherein said phase consists consisting essentially of
4% of p-cyanophenyl p-ethylbenzoate
4% of p-cyanophenyl p-propylbenzoate
4% of 4-cyano-3-fluorophenyl p-ethylbenzoate
4% of 4-cyano-3-fluorophenyl p-propylbenzoate
15% of p-trans-4-propylcylcohexyl-benzonitrile p- trans - 4 - propylcyclohexyl - benzonitrile
10% of p-trans-4-butylcyclohexyl-benzonitrile
14% of p-ethoxyphenyl trans-4-propylcyclohexanecarboxylate
10% of p-methoxyphenyl trans-4-butylcyclohexanecarboxylate
10% of p-methoxyphenyl trans-4-pentylcyclohexanecarboxylate
10% of p-ethoxyphenyl trans-4-butylcyclohexanecarboxylate
6% of p-(p-butylphenoxycarbonyl)-phenyl p-butylbenzoate
5% of p-propylphenyl trans-4-(p-propylphenoxycarbonyl)cyclohexane carboxylate and
4% of p-pentylphenyl trans-4-(p-pentylphenoxycarbonyl)cyclohexane carboxylate.
10. A liquid crystal phase according to claim 1 , wherein said phase consists consisting essentially of
10% of 4-cyano-3-fluorophenyl p-propylbenzoate
0.93% of p-propylphenyl trans-4-propylcyclohexane carboxylate
8.47% of p-pentylphenyl trans-4-propylcyclohexane carboxylate
6.6% of p-heptylphenyl trans-4-propylcyclohexane carboxylate
17% of 4-cyano-biphenyl-4′-yl trans-4-ethylcyclohexane carboxylate
10% of 4-pentyl-2-fluorophenyl trans-4-(trans-4-pentylcyclohexyl)-cyclohexane carboxylate
9% of trans-1-p-cyanophenyl-4-propylcyclohexane
4% of 4-ethyl-4′-cyanobiphenyl
14% of 2-p-cyanophenyl-5-propyl-1,3-dioxane and
14% of 2-p-cyanophenyl-5-pentyl-1,3-dioxane.
11. A liquid crystal phase according to claim 1 , wherein said phase consists essentially of
4% of 4-cyano-3-fluorophenyl p-propylbenzoate
16% of 4-cyano-biphenyl-4′-yl trans-4-ethylcyclohexane carboxylate
13.23% of p-propylphenyl trans-4-propylcyclohexane carboxylate
16.17% of p-pentylphenyl trans-4-propylcyclohexane carboxylate
b 12.6% of p-heptylphenyl trans-4-propylcyclohexane carboxylate
20% of trans-1-p-cyanophenyl-4-propylcyclohexane
13% of 4-pentyl-2-fluorophenyl 4-heptylbiphenyl-4′-carboxylate and
5% of 4-ethyl-4′-cyanobiphenyl.
12. In an electrooptical display element containing a liquid crystal phase, the improvement wherein said phase is a phase according to claim 1 .
13. A liquid crystal phase according to claim 1 , wherein the total proportion of compounds of formula I is 10-20 wt.%.
14. A liquid crystal phase according to claim 1 , wherein the total proportion of compounds of formulae I and II is 29-55 wt.%.
15. A liquid crystal phase according to claim 1 , wherein the total proportion of the components of formula III is 38-67 wt.%.
16. A liquid crystal phase according to claim 1 , wherein the total proportion of the components of formula IV is 4-15 wt.%.
17. A liquid crystal phase according to claim 1 , wherein the total proportion of the compounds of formula Va is 0-7 wt.%.
18. A liquid crystal phase according to claim 1 , wherein the total proportion of compounds of formulae I and II is more than 12 wt.%.
19. A liquid crystal phase according to claim 1 , wherein the total proportion of compounds of formulae I and II is 20-80 wt.%.Join the waitlist — get patent alerts
Track USRE37270E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.